Clinical Trial Update: Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer: [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pembrolizumab in combination with the FLOT chemotherapy regimen for gastroesophageal junction cancer; the study status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: xiaohua li | Conditions: Gastroesophageal Junction Cancer | Phase 3 | Status: NOT_YET_RECRUITING